Primary Health Properties plc R.E.I.T (PP51) Ratios
Primary Health Properties plc R.E.I.T Ratios
DE:PP51's free cash flow for Q2 2026 was $89.00M. For the 2026 fiscal year, DE:PP51's free cash flow was increased by $0.00 and operating cash flow was $89.00M. See a summary of the company’s cash flow.
| Ratios | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| Liquidity Ratios | |||||
| Current Ratio | 6.67 | 0.02 | 0.63 | 0.75 | 0.73 |
| Quick Ratio | 6.67 | 0.02 | 0.61 | 0.73 | 0.72 |
| Cash Ratio | 2.22 | 0.02 | 0.05 | 0.45 | 0.47 |
| Solvency Ratio | 0.03 | 0.03 | 0.02 | 0.04 | 0.10 |
| Operating Cash Flow Ratio | 11.56 | 0.63 | 2.11 | 1.24 | 1.42 |
| Short-Term Operating Cash Flow Coverage | 11.56 | 0.89 | 55.67 | 33.04 | 45.55 |
| Net Current Asset Value | $ -3.42B | $ -1.41B | $ -1.36B | $ -1.33B | $ -1.30B |
| Leverage Ratios | |||||
| Debt-to-Assets Ratio | 0.55 | 0.48 | 0.47 | 0.45 | 0.45 |
| Debt-to-Equity Ratio | 1.29 | 0.97 | 0.93 | 0.88 | 0.85 |
| Debt-to-Capital Ratio | 0.56 | 0.49 | 0.48 | 0.47 | 0.46 |
| Long-Term Debt-to-Capital Ratio | 0.56 | 0.46 | 0.48 | 0.47 | 0.46 |
| Financial Leverage Ratio | 2.36 | 2.03 | 1.99 | 1.93 | 1.90 |
| Debt Service Coverage Ratio | 2.17 | 0.45 | 0.02 | 3.79 | 3.14 |
| Interest Coverage Ratio | 2.38 | 2.21 | 1.78 | 4.03 | 5.99 |
| Debt to Market Cap | 1.88 | 1.07 | 0.95 | 0.88 | 0.63 |
| Interest Debt Per Share | 1.89 | 1.04 | 1.03 | 1.01 | 0.99 |
| Net Debt to EBITDA | 15.88 | 14.13 | 0.00 | 7.80 | 9.42 |
| Profitability Margins | |||||
| Gross Profit Margin | 89.58% | 85.69% | 88.93% | 91.82% | 93.13% |
| EBIT Margin | 79.92% | 51.62% | -0.53% | 105.91% | 90.87% |
| EBITDA Margin | 79.92% | 52.12% | 0.00% | 105.91% | 90.87% |
| Operating Profit Margin | 77.99% | 56.91% | 49.65% | 105.91% | 162.57% |
| Pretax Profit Margin | 47.10% | 25.87% | 15.37% | 36.92% | 97.25% |
| Net Profit Margin | 45.95% | 22.78% | 16.08% | 36.53% | 96.22% |
| Continuous Operations Profit Margin | 45.95% | 22.78% | 16.08% | 36.53% | 96.22% |
| Net Income Per EBT | 97.54% | 88.09% | 104.60% | 98.95% | 98.94% |
| EBT Per EBIT | 60.40% | 45.45% | 30.96% | 34.87% | 59.82% |
| Return on Assets (ROA) | 1.97% | 1.48% | 0.97% | 1.97% | 4.91% |
| Return on Equity (ROE) | 4.66% | 3.01% | 1.92% | 3.80% | 9.34% |
| Return on Capital Employed (ROCE) | 3.35% | 4.01% | 3.05% | 5.83% | 8.51% |
| Return on Invested Capital (ROIC) | 3.26% | 3.34% | -633.83% | 5.76% | 8.41% |
| Return on Tangible Assets | 1.97% | 1.49% | 0.97% | 1.97% | 4.91% |
| Earnings Yield | 6.78% | 3.32% | 1.97% | 3.81% | 6.96% |
| Efficiency Ratios | |||||
| Receivables Turnover | 6.47 | 10.44 | 9.99 | 13.06 | 11.93 |
| Payables Turnover | 3.00 | 14.44 | 7.52 | 3.82 | 16.67 |
| Inventory Turnover | 0.00 | 0.00 | 13.43 | 9.69 | 14.29 |
| Fixed Asset Turnover | 86.33 | 302.83 | 339.60 | 385.25 | 485.33 |
| Asset Turnover | 0.04 | 0.07 | 0.06 | 0.05 | 0.05 |
| Working Capital Turnover Ratio | -3.25 | -1.56 | -8.66 | -8.88 | 8.54 |
| Cash Conversion Cycle | -65.30 | 9.68 | 15.19 | -29.99 | 34.23 |
| Days of Sales Outstanding | 56.37 | 34.95 | 36.54 | 27.95 | 30.58 |
| Days of Inventory Outstanding | 0.00 | 0.00 | 27.18 | 37.66 | 25.55 |
| Days of Payables Outstanding | 121.67 | 25.27 | 48.54 | 95.60 | 21.90 |
| Operating Cycle | 56.37 | 34.95 | 63.72 | 65.61 | 56.13 |
| Cash Flow Ratios | |||||
| Operating Cash Flow Per Share | 0.06 | 0.10 | 0.10 | 0.06 | 0.08 |
| Free Cash Flow Per Share | 0.06 | 0.10 | 0.10 | 0.06 | 0.19 |
| Dividend Paid and CapEx Coverage Ratio | 0.72 | 1.47 | 1.49 | 0.97 | 0.45 |
| Capital Expenditure Coverage Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.68 |
| Operating Cash Flow Coverage Ratio | 0.03 | 0.10 | 0.10 | 0.06 | 0.08 |
| Operating Cash Flow to Sales Ratio | 0.40 | 0.74 | 0.79 | 0.51 | 0.69 |
| Free Cash Flow Yield | 5.92% | 10.84% | 9.63% | 5.36% | 12.24% |
| Valuation Ratios | |||||
| Price-to-Earnings (P/E) Ratio | 14.74 | 30.10 | 50.82 | 26.27 | 14.38 |
| Price-to-Sales (P/S) Ratio | 6.78 | 6.86 | 8.17 | 9.60 | 13.83 |
| Price-to-Book (P/B) Ratio | 0.69 | 0.91 | 0.97 | 1.00 | 1.34 |
| Price-to-Free Cash Flow (P/FCF) Ratio | 16.88 | 9.22 | 10.38 | 18.65 | 8.17 |
| Price-to-Operating Cash Flow Ratio | 16.88 | 9.22 | 10.38 | 18.65 | 20.10 |
| Price-to-Earnings Growth (PEG) Ratio | 0.13 | 0.58 | -0.98 | -0.43 | 0.59 |
| Enterprise Value Multiple | 24.36 | 27.29 | 0.00 | 16.87 | 24.64 |
| Enterprise Value | 5.04B | 2.58B | 2.71B | 2.75B | 3.26B |
| EV to EBITDA | 24.36 | 27.29 | 0.00 | 16.87 | 24.64 |
| EV to Sales | 19.47 | 14.22 | 15.96 | 17.86 | 22.39 |
| EV to Free Cash Flow | 48.48 | 19.12 | 20.29 | 34.71 | 13.22 |
| EV to Operating Cash Flow | 48.48 | 19.12 | 20.29 | 34.71 | 32.54 |
| Tangible Book Value Per Share | 1.43 | 1.03 | 1.06 | 1.11 | 1.13 |
| Shareholders’ Equity Per Share | 1.42 | 1.03 | 1.07 | 1.11 | 1.13 |
| Tax and Other Ratios | |||||
| Effective Tax Rate | 0.02 | 0.12 | -0.05 | 0.01 | 0.01 |
| Revenue Per Share | 0.14 | 0.14 | 0.13 | 0.12 | 0.11 |
| Net Income Per Share | 0.07 | 0.03 | 0.02 | 0.04 | 0.11 |
| Tax Burden | 0.98 | 0.88 | 1.05 | 0.99 | 0.99 |
| Interest Burden | 0.59 | 0.50 | -29.00 | 0.35 | 1.07 |
| Research & Development to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| SG&A to Revenue | 0.03 | 0.07 | 0.07 | 0.06 | 0.07 |
| Stock-Based Compensation to Revenue | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Income Quality | 0.87 | 3.27 | 4.89 | 1.41 | 0.72 |
Currency in GBP